Table 2 Estimated IC50 doses of breast cell lines treated with chemotherapeutics
From: EGFR associated expression profiles vary with breast tumor subtype
Cell Line | 5-Florouracil (uM) | Doxorubicin (nM) | Carboplatin (uM) | Paclitaxel (nM) |
|---|---|---|---|---|
ME16C | 6.0 (0.29) | 32.8 (1.89) | 37.5 (0.63) | 0.052 (0.004) |
HME-CC | 1.1 (0.07) | 35.5 (3.26) | 48.3 (1.41) | 0.025 (0.003) |
SUM102 | 16.8 (0.82) | 5.1 (0.27) | 11.7 (0.26) | 0.00057 (0.00001) |
SUM149 | 28.6 (1.33) | 45.0 (3.06) | 7.7 (0.24) | 0.71 (0.006) |
MCF-7 | 1.2 (0.15) | 56.9 (4.26) | 89.4 (3.79) | 0.23 (0.02) |
ZR-75-1 | 8.4 (1.06) | 26.5 (1.39) | 62.6 (1.98) | 0.99 (3.34) |